title: Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels.
authors.affiliation: Universitäts-Hautklinik Hamburg-Eppendorf, Hamburg, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Kowalzick
authors.forename: H
authors.initials: H
authors.lastname: Bildau
authors.forename: K
authors.initials: K
authors.lastname: Neuber
authors.forename: I
authors.initials: I
authors.lastname: Köhler
authors.forename: J
authors.initials: J
authors.lastname: Ring
mesh_terms: D000328:Adult; D000875:Anthralin / Q000276:immunology / Q000627:therapeutic use*; D015703:Antigens, CD / Q000097:blood*; D015815:Cell Adhesion Molecules / Q000097:blood*; D003131:Combined Modality Therapy; D006801:Humans; D018799:Intercellular Adhesion Molecule-1; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000628:therapy*; D012995:Solubility; D014467:Ultraviolet Therapy
chemical_list: D015703:Antigens, CD; D015815:Cell Adhesion Molecules; D018799:Intercellular Adhesion Molecule-1; D000875:Anthralin